Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
03/2013
03/07/2013US20130059866 Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
03/07/2013US20130059834 Pyrrolopyrazine kinase inhibitors
03/07/2013US20130058980 Small molecule inhibitors of protein kinases
03/07/2013US20130056690 Maleimide-based compound, and tautomer or stereoisomer thereof, dye for photoelectric conversion, and semiconductor electrode, photoelectric conversion element and photoelectrochemical cell using the same
03/07/2013DE102011082013A1 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine 6H-thieno [3,2-f] [1,2,4] triazolo [4,3-a] [1,4] diazepines
03/07/2013CA2846692A1 6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepines
03/06/2013EP2565194A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE
03/06/2013EP2563795A1 Inhibitors of protein tyrosine kinase activity
03/06/2013EP2563794A1 Inhibitors of protein tyrosine kinase activity and use thereof to treat ophthalmic disorders
03/06/2013CN102958937A Benzodioxole or benzodioxepine heterocyclic compounds phosphodiesterase inhibitors
03/06/2013CN102958936A Anellated pyridine compounds
03/06/2013CN102952146A Heterocyclic compound, organic light-emitting device, and flat display device
03/06/2013CN102046201B Inhibitor of analgesic tolerance
03/06/2013CN101817833B DPP-IV inhibitor
03/05/2013USRE44048 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL]benzenesulfonamide for the treatment of inflammation or an inflammation-associated disorder
03/05/2013US8389730 Compositions and methods for the treatment of disease associated with TRP-P8 expression
03/05/2013US8389669 Fused thiophenes, methods for making fused thiophenes, and uses thereof
02/2013
02/28/2013WO2013027801A1 Fused heterocyclic derivative and pharmaceutical use thereof
02/28/2013WO2013027693A1 Organic electroluminescent element, compound, and light emitting device, display device and lighting system, using said element
02/28/2013WO2013026900A1 Pyridine derivatives as microbiocides
02/28/2013WO2013026797A1 Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
02/28/2013US20130053569 Process for the preparation of prasugrel hcl salt
02/28/2013US20130053555 Organic electroluminescent devices
02/28/2013US20130053401 Thieno [2,3-b] pyridinedione activators of ampk and therapeutic uses thereof
02/28/2013US20130053370 THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY ON PROTEIN KINASES
02/28/2013US20130053363 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE
02/28/2013US20130048955 Heterocyclic compound and organic light-emitting device containing the same
02/28/2013CA2846183A1 Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
02/27/2013EP2561872A1 3, 5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo [4,5-d]pyrimidin-2-one compounds and prodrugs thereof
02/27/2013CN102947963A Organic semiconductive material precursor containing dithienobenzodithiophene derivative, ink, insulating member, charge-transporting member, and organic electronic device
02/27/2013CN102947316A Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activity
02/27/2013CN102947315A Inhibitors of protein tyrosine kinase activity
02/27/2013CN102947314A Dithiinopyridazine-dion derivatives
02/27/2013CN102947310A Anellated pyridine compounds as dual modulators of the 5-HT2A and D3 receptors
02/27/2013CN102942573A Preparation method of olanzapine
02/26/2013CA2542076C Substituted tricyclic compounds as protein kinase inhibitors
02/21/2013WO2013025733A1 Lysophosphatidic acid receptor antagonists
02/21/2013WO2013024399A1 Improved method for quantitative determination of prasugrel hydrochloride
02/21/2013WO2013024291A2 Therapeutically active fused pyrimidine derivatives
02/21/2013WO2012065139A3 Entpd5 inhibitors
02/21/2013US20130045229 Anti-Viral Compounds
02/21/2013US20130042918 Oligothiophenes
02/21/2013CA2844982A1 Lysophosphatidic acid receptor antagonists
02/20/2013EP2558473A1 Method for producing dithiine tetracarboximides
02/20/2013EP2558472A1 Method for producing dithiine tetracarboxy-diimides
02/20/2013EP2558471A1 Thienodithiin derivatives as fungicides
02/20/2013EP2558470A1 Dithiinopyridazine-dion derivatives
02/20/2013EP2558446A1 Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
02/20/2013CN102939294A Process for preparing dithiine-tetracarboxy-diimides
02/20/2013CN102939293A Thienodithiin derivatives as fungicides
02/20/2013CN102939282A Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
02/20/2013CN102936245A Preparation for photoelectric material
02/19/2013US8378123 Composition, synthesis, and use of new substituted pyran and pterin compounds
02/19/2013US8377944 Thienopyrimidine derivatives
02/19/2013CA2583053C Functionalized heteroacenes and electronic devices generated therefrom
02/19/2013CA2532798C Azepine derivatives as pharmaceutical agents
02/14/2013WO2013023109A1 Coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling (coupled tricyclic core compounds)
02/14/2013WO2013023108A1 Coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling (heteroarylene spacer moiety)
02/14/2013WO2013023107A1 Coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling (electron withdrawing groups)
02/14/2013WO2013023106A1 Coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling (acyl moieties)
02/14/2013WO2013022047A1 Cyclopropaneamine compound
02/14/2013WO2013021953A1 Condensed polycyclic aromatic compound, aromatic polymer, and method for synthesizing aromatic compound
02/14/2013WO2013020992A1 Dihydrothienopyrimidines
02/14/2013WO2013020164A1 Compounds for treating respiratory syncytial virus infections
02/14/2013US20130040975 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
02/14/2013US20130040957 Deuterium-Enriched Pyrimidine Compounds and Derivatives
02/14/2013US20130040941 Benzodiazepine compound and pharmaceutical composition
02/14/2013US20130037752 Electroluminescent materials comprising fluorene derivatives
02/14/2013CA2844525A1 Cyclopropaneamine compound
02/13/2013EP2557081A1 Thienopyridine derivative, method for producing same and organic semiconductor device using same
02/13/2013EP2556075A1 Substituted carbazole derivatives and use thereof in organic electronics
02/13/2013CN102933582A Substituted carbazole derivatives and use thereof in organic electronics
02/13/2013CN102924474A Preparation method of crystal form I of clopidogrel hydrogen sulfate
02/13/2013CN102924473A Preparation method of 2-chlorine-7-iodothieno[3,2-D] pyrimidine
02/13/2013CN102924472A Preparation method for olanzapine
02/13/2013CN102924471A 3,4-ethylenedioxythiophene preparation method
02/13/2013CN102924470A Olanzapine preparation method
02/13/2013CN102924377A Synthetic method of 3,4,5-substituted pyrazole compound
02/13/2013CN102924217A Fluorene and pyrene derivatives and organic electroluminescent device using the same
02/13/2013CN101445469B Inhibitors of histone deacetylase
02/12/2013US8372981 Nitrogen-containing aromatic derivatives
02/12/2013US8372880 Compositions and methods using same for treating amyloid-associated diseases
02/12/2013CA2596527C Igf-1r inhibitors
02/12/2013CA2530281C Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders
02/07/2013WO2013019966A1 Aromatic bycyclic derivatives as cxcr4 receptor modulators
02/07/2013WO2013018967A1 High-conductivity hole transport material and dye-sensitized solar cell using same
02/07/2013WO2013018928A1 Fused heterocyclic compound and use thereof for pest control
02/07/2013WO2013018899A1 Dibenzooxepin derivative
02/07/2013WO2013018658A1 Polymer compound and organic transistor using same
02/07/2013WO2013017026A1 Hcv protease inhibitors
02/07/2013US20130035355 Prasugrel in micronized, crystalline form and pharmaceutical composition thereof
02/07/2013US20130035347 Aromatic bycyclic derivatives as cxcr4 receptor modulators
02/07/2013US20130032791 Conjugated polymers having an imine group at the intrachain electron donor bridgehead position useful in electronic devices
02/07/2013CA2844241A1 Fused heterocyclic compound and use thereof for pest control
02/06/2013EP2552891A1 Tricyclic indole derivatives as pbr ligands
02/06/2013EP2552206A1 Trycyclic compounds and pbk inhibitors containing the same
02/05/2013US8367653 Azetidinyl diamides as monoacylglycerol lipase inhibitors
02/05/2013CA2579000C Novel 3-thia-10-aza-phenanthrene derivatives
02/05/2013CA2508792C Heterocyclic compounds, methods of making them and their use in therapy
01/2013
01/31/2013WO2013015535A2 Novel pyrimidine derivative and pharmaceutical composition including same as an active ingredient
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 214